Insys Therapeutics (INSY) COO Terminated
- Stocks dip as earnings pour in, consumer discretionary lags
- UPDATE: Alphabet (GOOG) Tops Q3 EPS Views; Revs Strong
- Twitter (TWTR) Tops Q3 EPS by 4c; Announces Restructuring, Workforce Reduction
- Cirrus Logic, Inc. (CRUS) Q2 Results and Guidance Beat Estimates
- Amazon.com (AMZN) Misses Q3 EPS by 26c, Offers Q4 Guidance
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Insys Therapeutics (NASDAQ: INSY) said Dan Brennan, the former Executive Vice President and Chief Operating Officer of Insys Therapeutics, Inc., was terminated.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: KKR & Co. (KKR) said to be investor in Netscout Systems (NTCT)
- EQT Corp. (EQT) Tops Q3 EPS by 15c; Announces CEO Succession
- NYSE to Immediately Suspend Trading in Violin Memory (VMEM) Shares; Will Move to Delist
Create E-mail Alert Related CategoriesHot Mgmt Changes, Management Changes, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!